Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.21.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Restricted cash $ 40,736 $ 35,986
Notes receivable, net 401,564 409,349
Receivable backed notes payable - non-recourse $ 364,933 $ 355,833
Preferred stock, par value $ 0.01 $ 0.01
Preferred stock, shares authorized 10,000,000 10,000,000
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 18,297 $ 20,469
Notes receivable, net 269,082 292,021
Receivable backed notes payable - non-recourse $ 325,317 $ 341,532
Class A Common Stock [Member]    
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 15,624,123 15,624,091
Common stock, shares outstanding 15,624,123 15,624,091
Class B Common Stock [Member]    
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 4,000,000 4,000,000
Common stock, shares issued 3,693,564 3,693,596
Common stock, shares outstanding 3,693,564 3,693,596